Screener
Rigel Pharmaceuticals RIGL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's enterprise value?
- Rigel Pharmaceuticals (RIGL) reported enterprise value of $543.41M in Q1 2026.
- How has Rigel Pharmaceuticals's enterprise value changed year-over-year?
- Rigel Pharmaceuticals's enterprise value increased by 96.3% year-over-year, from $276.89M to $543.41M.
- What is the long-term trend for Rigel Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's enterprise value has grown at a 6.9% compound annual growth rate (CAGR), from $587.45M to $820.29M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Rigel Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude